The utility of ChatGPT for cancer treatment information

Abstract

The use of large language models (LLMs) such as ChatGPT for medical question-answering is becoming increasingly popular. However, there are concerns that these models may generate and amplify medical misinformation. Because cancer patients frequently seek to educate themselves through online resources, some individuals will likely use ChatGPT to obtain cancer treatment information. This study evaluated the performance and robustness of ChatGPT in providing breast, prostate, and lung cancer treatment recommendations that align with National Comprehensive Cancer Network (NCCN) guidelines. Four prompt templates were created to explore how differences in how the query is posed impacts response. ChatGPT output was scored by 3 oncologists and a 4th oncologist adjudicated in cases of disagreement. ChatGPT provided at least one NCCN-concordant recommendation for 102/104 (98%) prompts. However, 35/102 (34.3%) of these also included a recommendation that was at least partially non-concordant with NCCN guidelines. Responses varied based on prompt type. In conclusion, ChatGPT did not perform well at reliably and robustly providing cancer treatment recommendations. Patients and clinicians should be aware of the limitations of ChatGPT and similar technologies for self-education.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

The authors thank the Woods Foundation for their generous support of this work.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.

Yes

留言 (0)

沒有登入
gif